NATHAN SHANK: Open Payments
NPI 1164940466 · OMAHA, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$81 in 4 payments from 4 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $81
Food & beverage: $81
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 1 | $28 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $20 |
| PFIZER INC. | 1 | $19 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $14 |
Products named: Veozah, CAPLYTA, VYNDAMAX, Kerendia.
Industry payments across NE — which companies pay providers there.
